Serotonin metabolite excretion after postmenopausal estradiol therapy

Maturitas

Volumn 24, Issue 1-2, 1996, Pages 37-41

  Lippert, Theodor H ^a   Filshie, Marcus ^b   Mück, Alfred O ^a   Seeger, Harald ^a   Zwirner, Manfred ^a  

^a Dept of Obstetrics and Gynecology ^*  (Germany)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

5 Hydroxyindole acetic acid; Estradiol; Postmenopause

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; CREATININE; ESTRADIOL; ESTROGEN; ESTRONE; SEROTONIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; HEART PROTECTION; HUMAN; MOOD; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; SEROTONINERGIC SYSTEM; TRANSDERMAL DRUG ADMINISTRATION; URINE LEVEL; WELLBEING;

EID: 0029992824     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5122(95)00998-1     Document Type: Article

References (19)

1. Slemenda CW, Johnston CC Jr. Epidemiology of osteoporosis. In: Lobo RA, ed. Treatment of the postmenopausal women: basic and clinical aspects. New York: Raven Press, 1994; 161-195.
2. Stampfer MJ, Grodstein F. Role of hormone replacement in cardiovascular disease. In: Lobo RA, ed. Treatment of the postmenopausal women: basic and clinical aspects. New York: Raven Press. 1994; 223-233.
3. Gangar KF, Vyas S, Whitehead M, Crook D, Meire H, Campbell S. Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause. Lancet 1991; 338: 839-842
4. Mück AO, Seeger H, Wiesner J, Korte K, Lippert TH. Urinary prostanoids in postmenopausal women after transdermal and oral estrogen therapy. J Obstet Gynecol 1994; 14: 341-345.
5. Mück AO, Seeger H, Korte K, Haasis R, Lippert TH. Beeinflußt Östradiol das NO/cGMP-System der Gefäße? Untersuchungen zum Mechanismus der kardiovaskulären Protektion durch Östrogensubstitution in der Postmenopause. Zentralbl Gynäkol 1994; 116: 507-511.
6. Meltzer HY, Nash JF. Neuroendocrine studies of 5-HT and mood. In: Ganten D, Pfaff D, eds. Current topics in neuroendocrinology, Vol. 8. Berlin: Springer-Verlag, 1988; 181-210.
7. Meltzer HY. Role of serotonin in depression. Ann NY Acad Sci 1990; 600: 486-500.
8. Fozard JR The peripheral actions of 5 hydroxytryptamine. Oxford: Oxford University Press, 1989.
9. Bergmeyer HU, Grassi M, Walter H-E. In: Bergmeyer HU, ed. Methods of enzymatic analysis, Vol. 2. Weinheim: VCH, 1983; 206-207.
10. Gonzales GF, Carillo C. Blood serotonin levels in postmenopausal women: effects of age and serum oestradiol levels. Maturitas 1993; 17: 23-29.
11. Golino P, Piscione F, Willerson JT et al. Divergent effects of serotonin on coronary-artery dimensions and blood flow in patients with coronary atherosclerosis and control patients. N Engl J Med 1991; 324: 641-648.
12. McFadden EP, Clarke JG, Davies GJ et al. Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina. N Engl J Med 1991; 324: 648-654.
13. Luotola H. Blood pressure and hemodynamics in postmenopausal women during estradiol 17-beta substitution. Ann Clin Res 1983; 15 Suppl 38: 1-121.
14. Pfeffer RI. Estrogen use, hypertension and stroke in postmenopausal women. J Chronic Dis 1978; 31: 389-398.
15. Rapkin AJ. The role of serotonin in premenstrual syndrome. Clin Obstet Gynaecol 1992; 35: 629-636.
16. Studd JWW, Smith RN. Estrogens and depression in women. Menopause 1994; 1: 33-37.
17. Powers MS, Schenkel L, Darley PE, Good WR, Balestra JC, Place VA. Pharmacokinetics and pharmacodynamics of transdermal dosage forms of 17β-estradiol: comparison with conventional oral estrogens used for hormone replacement. Am J Obstet Gynecol 1985; 152: 1099-1106.
18. Rapkin AJ, Edelmuth E, Chang LC, Reading AE, McGuire MT, Su TP. Whole-blood serotonin in premenstrual syndrome. Obstet Gynecol 1987; 70: 533-537.
19. Haspels AA, Coeling Bennink JHT, Schreurs WHP. Disturbance of tryptophan metabolism and its correction during oestrogen treatment in postmenopausal women. Maturitas 1978; 1: 15-20.